Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prophylacticConcizumab in patients with haemophilia A or B with inhibitors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia with Inhibitors

Drugs mentioned

• Concizumab (concizumab)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Phase 2 | Status: COMPLETED | Results posted: 2021-10-22